CHWY vs SRPT · P/E 45, rev $12.60B vs rev $1.13B
Chewy Inc (CHWY) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Chewy Inc (CHWY) is a internet retail company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CHWY revenue for 2026-02-01 was $12.60B. Net income was $222.8M. Revenue was up 6.2% from 2025-02-02 to 2026-02-01. CHWY currently screens at market cap $16.92B and trailing P/E 45.0.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
CHWY currently screens at market cap $16.92B and trailing P/E 45.0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CHWY and SRPT stock pages for the full models.
Not investment advice.